Skip to content

Study effect of dexmedetomidine drug during laparoscopic cholecystectomy

A study to evaluate the effect of dexmedetomidine on haemodynamic response in untreated stage1 hypertensive patients undergoing laproscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026594
Enrollment
60
Registered
2020-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: Dexmedetomidine infusion: After Loading dose of 1mcg per kg over 10 minutes ,dexmedetomidine at rate of 0.2mcg/kg/hr started through intraoperative period Control Intervention1: Normal

Sponsors

Pt B DSHARMA PGIMS ROHTAK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Asa 1&2 Either sex Posted for laproscopic cholecystectomy Stage 1 hypertensive patients,not on any medication

Exclusion criteria

Exclusion criteria: Patients with difficult airway Stage 2 hypertensive Patients on antihypertensive medication Patients with cardiac,renal,hepatic or endocrine disease Pregnant or morbid obese Allergic to dexmedetomidine

Design outcomes

Primary

MeasureTime frame
To investigate effect of dexmedetomidine on hemodynamic response to laryngoscopy,intubation,pneumoperitoneum and extubation in stage 1 hypertensive patients undergoing laproscopic cholecystectomyTimepoint: To investigate effect of dexmedetomidine on hemodynamic response to laryngoscopy,intubation,pneumoperitoneum 15 minutes,release of pneumoperitoneum and extubation in stage 1 hypertensive patients undergoing laproscopic cholecystectomy during perioperative period.

Secondary

MeasureTime frame
To observe time to extubate trachea,time to first rescue analgesia and post operative sedation score at 1 min, 15 minutes, 30 minutes and 60 minutes.Timepoint: Any adverse effects like hypotension,bradycardia and excessive sedation during perioperative period and sedation score at 1 minute, 15 minute,30 minutes and 60 minutes.

Countries

India

Contacts

Public ContactDrSudesh

PGIMS ROHTAK

dr.sudeshkr@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026